Table 4.

Assay of serum markers of control and rats treated with lithium carbonate (Li), CCE, or their combination (CCE + Li).

	Treatment groups
Parameters	C	Li	CCE	CCE + Li
Glucose (mmol/L)	4.85 ± 0.25	7.02 ± 0.41b	4.99 ± 0.41d	5.46 ± 0.46d
Cholesterol (mmol/L)	1.40 ± 0.06	2.87 ± 0.12b	1.43 ± 0.09d	1.46 ± 0.25d
Triglycerides (mmol/L)	1.08 ± 0.1	1.74 ± 0.05b	1.07 ± 0.1d	1.16 ± 0.3d
AST (U/L)	150 ± 0.9	345 ± 0.3b	166 ± 0.1d	240 ± 1.4d
ALT (U/L)	71 ± 0.08	122 ± 0.2b	68.5 ± 1.1d	85.4 ± 0.9d
LDH (U/L)	877 ± 8.2	1101 ± 5.2b	872 ± 2.4d	845 ± 4.1d
ALP (U/L)	54 ± 8.1	85 ± 2.9b	56 ± 1.73d	50 ± 4.50d

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; LDH: lacatate dehydrogenase; ALP: alkaline phosphatase. Data are expressed as mean ± standard deviation (SD) for six rats in each group. Statistical comparison was performed using Student’s test.

^b p < 0.01 compared with control group (C).

^d p < 0.01 compared with lithium carbonate-treated group (Li).